In India hip fracture is associated with high rates of mortality and disability

In various studies across different countries the reported one year mortality risks after hip fracture can vary anywhere from 5 to 50 %. In India, however, there has been little research on the risk of mortality and functional impairment following hip fracture.

In an oral presentation held during the European Congress on & Osteoarthritis in Rome, Italy, held from April 17 to 20 in Rome, Italy, researchers from Maulana Azad Medical College, New Delhi, presented findings from a prospective study which found that patients had a high rate of one-year mortality and .

The study included 188 patients (mean age 64.67, 60% women) with fragility admitted to the hospital over a three and half-year period. The follow up on 174 of these patients showed that 30.4 % had died within one year, with the majority of deaths occurring within the first six months after fracture. Only around one-fifth (21.9 %) of the patients were able to return to normal motor function. The remaining needed assistance for their daily life activities: 13.7 % were bed ridden, 14.9 % could only walk with a cane, and 19.5% required a walker (zimmer frame). (OC20)

Abstracts have been published in Osteoporosis International, Vol. 24, Suppl. 1, 2013.

add to favorites email to friend print save as pdf

Related Stories

Healthy bones program reduces hip fractures by 37 percent

Nov 04, 2008

Proactive measures can reduce hip fracture rates by an average of 37.2 percent -- and as much as 50 percent -- among those at risk, according to a study conducted by Kaiser Permanente Southern California. The study was published ...

Recommended for you

Streets bustling after Sierra Leone shutdown ends

2 hours ago

Streets in Sierra Leone's capital bustled again Monday after an unprecedented nationwide shutdown during which officials said more than 1 million households were checked for Ebola patients and given information ...

Spain: Ebola test drug out of supply worldwide

4 hours ago

Doctors treating a Spanish priest who was repatriated from West Africa on Monday after being diagnosed with the Ebola virus said there were no samples of experimental drug ZMapp available in the world right ...

User comments